Outpace Bio, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2020-11-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.outpacebio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer
- Interventions
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Outpace Bio, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT07030907
- Locations
- πΊπΈ
University of Minnesota, Minneapolis, Minnesota, United States
πΊπΈRoswell Park, Buffalo, New York, United States
πΊπΈMD Anderson Cancer Center, Houston, Texas, United States
News
No news found